LISA DIASIO: Open Payments
NPI 1972862423 · LANGHORNE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$927 in 34 payments from 11 companies in 2025. Trend: 2023 $360 · 2024 $627 · 2025 $927
Food & beverage: $828Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $236 |
| Amgen Inc. | 4 | $162 |
| Sage Therapeutics, LLC | 5 | $151 |
| Sumitomo Pharma America, Inc. | 4 | $89 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $66 |
| Exeltis, USA Inc. | 3 | $64 |
| Supernus Pharmaceuticals, Inc. | 2 | $49 |
| CooperSurgical, Inc. | 2 | $44 |
| Hologic Sales and Service, LLC | 1 | $26 |
| MILLICENT US INC | 1 | $23 |
Products named: EVENITY, ZURZUVAE, Veozah, MYFEMBREE, SLYND, Qelbree, Paragard T 380A, APTIMA.
Industry payments across PA — which companies pay providers there.
